Yanjie Liu1, Emilisa Frirdich2, Jennifer A Taylor3,4, Anson C K Chan2, Kris M Blair3,5, Jenny Vermeulen2, Reuben Ha2, Michael E P Murphy2, Nina R Salama3,4,5, Erin C Gaynor2, Martin E Tanner1. 1. Contribution from the Department of Chemistry, University of British Columbia , Vancouver, British Columbia V6T 1Z1, Canada. 2. Department of Microbiology and Immunology, University of British Columbia , Vancouver, British Columbia V6T 1Z3, Canada. 3. Division of Human Biology, Fred Hutchinson Cancer Research Center , Seattle, Washington 98109, United States. 4. Department of Microbiology, University of Washington School of Medicine , Seattle, Washington 98195, United States. 5. Program in Molecular and Cellular Biology, University of Washington , Seattle, Washington 98195, United States.
Abstract
Helicobacter pylori and Campylobacter jejuni are human pathogens and causative agents of gastric ulcers/cancer and gastroenteritis, respectively. Recent studies have uncovered a series of proteases that are responsible for maintaining the helical shape of these organisms. The H. pylori metalloprotease Csd4 and its C. jejuni homologue Pgp1 cleave the amide bond between meso-diaminopimelate and iso-d-glutamic acid in truncated peptidoglycan side chains. Deletion of either csd4 or pgp1 results in bacteria with a straight rod phenotype, a reduced ability to move in viscous media, and reduced pathogenicity. In this work, a phosphinic acid-based pseudodipeptide inhibitor was designed to act as a tetrahedral intermediate analog against the Csd4 enzyme. The phosphinic acid was shown to inhibit the cleavage of the alternate substrate, Ac-l-Ala-iso-d-Glu-meso-Dap, with a Ki value of 1.5 μM. Structural analysis of the Csd4-inhibitor complex shows that the phosphinic acid displaces the zinc-bound water and chelates the metal in a bidentate fashion. The phosphinate oxygens also interact with the key acid/base residue, Glu222, and the oxyanion-stabilizing residue, Arg86. The results are consistent with the "promoted-water pathway" mechanism for carboxypeptidase A catalysis. Studies on cultured bacteria showed that the inhibitor causes significant cell straightening when incubated with H. pylori at millimolar concentrations. A diminished, yet observable, effect on the morphology of C. jejuni was also apparent. Cell straightening was more pronounced with an acapsular C. jejuni mutant strain compared to the wild type, suggesting that the capsule impaired inhibitor accessibility. These studies demonstrate that a highly polar compound is capable of crossing the outer membrane and altering cell shape, presumably by inhibiting cell shape determinant proteases. Peptidoglycan proteases acting as cell shape determinants represent novel targets for the development of antimicrobials against these human pathogens.
Helicobacter pylori and n class="Species">Campylobacter jejuniare human pathogens and causative agents of gastric ulcers/cancer and gastroenteritis, respectively. Recent studies have uncovered a series of proteases that are responsible for maintaining the helical shape of these organisms. The H. pylorimetalloprotease Csd4 and its C. jejuni homologue Pgp1 cleave the amide bond between meso-diaminopimelate and iso-d-glutamic acid in truncated peptidoglycan side chains. Deletion of either csd4 or pgp1 results in bacteria with a straight rod phenotype, a reduced ability to move in viscous media, and reduced pathogenicity. In this work, a phosphinic acid-based pseudodipeptide inhibitor was designed to act as a tetrahedral intermediate analog against the Csd4 enzyme. The phosphinic acid was shown to inhibit the cleavage of the alternate substrate, Ac-l-Ala-iso-d-Glu-meso-Dap, with a Ki value of 1.5 μM. Structural analysis of the Csd4-inhibitor complex shows that the phosphinic acid displaces the zinc-bound water and chelates the metal in a bidentate fashion. The phosphinateoxygens also interact with the key acid/base residue, Glu222, and the oxyanion-stabilizing residue, Arg86. The results are consistent with the "promoted-water pathway" mechanism for carboxypeptidase A catalysis. Studies on cultured bacteria showed that the inhibitor causes significant cell straightening when incubated with H. pylori at millimolar concentrations. A diminished, yet observable, effect on the morphology of C. jejuni was also apparent. Cell straightening was more pronounced with an acapsularC. jejuni mutant strain compared to the wild type, suggesting that the capsule impaired inhibitor accessibility. These studies demonstrate that a highly polar compound is capable of crossing the outer membrane and altering cell shape, presumably by inhibiting cell shape determinant proteases. Peptidoglycan proteases acting as cell shape determinants represent novel targets for the development of antimicrobials against these human pathogens.
Authors: Laura K Sycuro; Zachary Pincus; Kimberley D Gutierrez; Jacob Biboy; Chelsea A Stern; Waldemar Vollmer; Nina R Salama Journal: Cell Date: 2010-05-28 Impact factor: 41.582
Authors: Doo Ri An; Ha Na Im; Jun Young Jang; Hyoun Sook Kim; Jieun Kim; Hye Jin Yoon; Dusan Hesek; Mijoon Lee; Shahriar Mobashery; Soon-Jong Kim; Se Won Suh Journal: PLoS One Date: 2016-10-06 Impact factor: 3.240
Authors: Diane Esson; Alison E Mather; Eoin Scanlan; Srishti Gupta; Stefan P W de Vries; David Bailey; Simon R Harris; Trevelyan J McKinley; Guillaume Méric; Sophia K Berry; Pietro Mastroeni; Samuel K Sheppard; Graham Christie; Nicholas R Thomson; Julian Parkhill; Duncan J Maskell; Andrew J Grant Journal: Sci Rep Date: 2016-12-02 Impact factor: 4.379
Authors: Paula Roszczenko-Jasińska; Marta Ilona Wojtyś; Elżbieta K Jagusztyn-Krynicka Journal: Appl Microbiol Biotechnol Date: 2020-10-14 Impact factor: 4.813